{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T03:31:36Z","timestamp":1786505496439,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001688","name":"International Centre for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","award":["CRP\/20\/017"],"award-info":[{"award-number":["CRP\/20\/017"]}],"id":[{"id":"10.13039\/501100001688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.meegid.2026.105970","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T22:03:41Z","timestamp":1781474621000},"page":"105970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association of host metabolizing gene profiles with isoniazid and rifampicin resistance phenotypes among tuberculosis patients in Bangladesh"],"prefix":"10.1016","volume":"143","author":[{"given":"Mohammad Khaja Mafij","family":"Uddin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aar Rafi","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashabul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannatul","family":"Ferdous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumana","family":"Nasrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossain Md.","family":"Faruquee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M. Mazidur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjan","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayera","family":"Banu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2026.105970_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2021.106355","article-title":"Central monitoring in a randomized, open-label, controlled phase 3 clinical trial for a treatment-shortening regimen for pulmonary tuberculosis","volume":"104","author":"Bryant","year":"2021","journal-title":"Contemp. Clin. Trials"},{"issue":"4","key":"10.1016\/j.meegid.2026.105970_bb0010","first-page":"153","article-title":"GSTM1 and GSTT1 genetic polymorphisms and their association with antituberculosis drug-induced liver injury","volume":"12","author":"Chanhom","year":"2020","journal-title":"Biomed. Rep."},{"issue":"4","key":"10.1016\/j.meegid.2026.105970_bb0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2710.2009.01101.x","article-title":"GSTT1 and GSTM1 gene deletions are not associated with hepatotoxicity caused by antitubercular drugs","volume":"35","author":"Chatterjee","year":"2010","journal-title":"J. Clin. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.meegid.2026.105970_bb0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF03262213","article-title":"Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs","volume":"16","author":"Costa","year":"2012","journal-title":"Mol. Diagn. Ther."},{"issue":"2","key":"10.1016\/j.meegid.2026.105970_bb0025","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/toxsci\/49.2.156","article-title":"Concise review of the glutathione S-transferases and their significance to toxicology","volume":"49","author":"Eaton","year":"1999","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.meegid.2026.105970_bb0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2131\/jts.33.187","article-title":"Effects of N-acetyltransferase 2 (NAT2), CYP2E1 and Glutathione-S-transferase (GST) genotypes on the serum concentrations of isoniazid and metabolites in tuberculosis patients","volume":"33","author":"Fukino","year":"2008","journal-title":"J. Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.meegid.2026.105970_bb0035","first-page":"224","article-title":"A simple method of genomic DNA extraction from human samples for PCR-RFLP analysis","volume":"24","author":"Ghatak","year":"2013","journal-title":"J. Biomol. Tech."},{"issue":"1","key":"10.1016\/j.meegid.2026.105970_bb0040","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/ijmr.IJMR_2013_15","article-title":"N-acetyltransferase gene polymorphisms & plasma isoniazid concentrations in patients with tuberculosis","volume":"145","author":"Hemanth Kumar","year":"2017","journal-title":"Indian J. Med. Res."},{"issue":"19","key":"10.1016\/j.meegid.2026.105970_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911028","article-title":"GSTT1\/GSTM1 genotype and anti-tuberculosis drug-induced hepatotoxicity in Peruvian patients","volume":"23","author":"Jaramillo-Valverde","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.meegid.2026.105970_bb0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tube.2009.12.001","article-title":"GSTT1 and GSTM1 null mutations and adverse reactions induced by antituberculosis drugs in Koreans","volume":"90","author":"Kim","year":"2010","journal-title":"Tuberculosis (Edinb.)"},{"issue":"7","key":"10.1016\/j.meegid.2026.105970_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071417","article-title":"Mechanism investigation of rifampicin-induced liver injury using comparative toxicoproteomics in mice","volume":"18","author":"Kim","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.meegid.2026.105970_bb0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1183\/09031936.00188313","article-title":"Management of patients with multidrug-resistant\/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement","volume":"44","author":"Lange","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.meegid.2026.105970_bb0065","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1478-3231.2008.01700.x","article-title":"Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population","volume":"28","author":"Leiro","year":"2008","journal-title":"Liver Int."},{"issue":"11","key":"10.1016\/j.meegid.2026.105970_bb0070","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.bcp.2011.08.003","article-title":"Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: rifampicin, rifabutin, and rifapentine","volume":"82","author":"Nakajima","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.meegid.2026.105970_bb0075","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tube.2014.02.003","article-title":"Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity","volume":"94","author":"Singla","year":"2014","journal-title":"Tuberculosis (Edinb.)"},{"issue":"5","key":"10.1016\/j.meegid.2026.105970_bb0080","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/jac\/dkn330","article-title":"Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs","volume":"62","author":"Sousa","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.meegid.2026.105970_bb0085","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1080\/21655979.2021.2003930","article-title":"Study on the associations between liver damage and antituberculosis drug rifampicin and relative metabolic enzyme gene polymorphisms","volume":"12","author":"Su","year":"2021","journal-title":"Bioengineered"},{"issue":"6","key":"10.1016\/j.meegid.2026.105970_bb0090","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1590\/S0074-02762011000600011","article-title":"Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients","volume":"106","author":"Teixeira","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"6","key":"10.1016\/j.meegid.2026.105970_bb0095","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00228-006-0111-5","article-title":"CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis","volume":"62","author":"Vuilleumier","year":"2006","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.meegid.2026.105970_bb0100","series-title":"WHO Global TB Report","year":"2020"},{"key":"10.1016\/j.meegid.2026.105970_bb0105","series-title":"WHO Global TB Report","year":"2024"}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134826000948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134826000948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T03:23:13Z","timestamp":1786504993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134826000948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":21,"alternative-id":["S1567134826000948"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2026.105970","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of host metabolizing gene profiles with isoniazid and rifampicin resistance phenotypes among tuberculosis patients in Bangladesh","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2026.105970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105970"}}